Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 36
Summary
- Conditions
- Metabolic Syndrome
- Metabolically Abnormal Obesity
- Metabolically Normal Obesity
- Non Alcoholic Fatty Liver Disease
- Obesity
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 90 years
- Gender
- Both males and females
Description
The purpose of this study is to determine the specific cellular and organ system metabolic and immunologic alterations that are associated with insulin resistance and inflammation in order to identify putative mechanisms and novel bio-markers involved in the pathogenesis and progression of inflammat...
The purpose of this study is to determine the specific cellular and organ system metabolic and immunologic alterations that are associated with insulin resistance and inflammation in order to identify putative mechanisms and novel bio-markers involved in the pathogenesis and progression of inflammatory and cardiometabolic diseases.
Tracking Information
- NCT #
- NCT01104220
- Collaborators
- Pfizer
- Investigators
- Principal Investigator: Samuel Klein, M.D. Washington University School of Medicine
Get Well Soon